The aptamer-targeted nanoparticles could efficiently deliver cargoes into MDA-MB-231 breast tumor with overexpressed nucleolin receptors, and folate-decorated nanoparticles delivering RNP targeting Plk1 exhibited significant gene disruption and tumor growth inhibition in vivo (Figure 16B). Here, PLK1 is linked to neoplasm.